LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 55.99 | 771.67 | 1608 | 7690 | 0.2091 | 0.2478 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.21 | 771.67 | 1419 | 8085 | 0.1755 | 0.1969 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.21 | 771.67 | 1616 | 8085 | 0.1999 | 0.2437 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.44 | 771.67 | 1438 | 8530 | 0.1686 | 0.1967 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.44 | 771.67 | 1575 | 8530 | 0.1846 | 0.2285 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.66 | 771.67 | 1440 | 8978 | 0.1604 | 0.1927 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.66 | 771.67 | 1593 | 8978 | 0.1774 | 0.2272 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.88 | 771.67 | 1445 | 9447 | 0.1530 | 0.1896 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.88 | 771.67 | 1579 | 9447 | 0.1671 | 0.2191 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.10 | 771.67 | 1449 | 9800 | 0.1479 | 0.1875 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.10 | 771.67 | 1604 | 9800 | 0.1637 | 0.2209 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.32 | 771.67 | 1461 | 10212 | 0.1431 | 0.1869 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.32 | 771.67 | 1616 | 10212 | 0.1582 | 0.2194 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.54 | 771.67 | 1477 | 10532 | 0.1402 | 0.1879 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.54 | 771.67 | 1608 | 10532 | 0.1527 | 0.2150 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 73.76 | 771.67 | 1501 | 10851 | 0.1383 | 0.1906 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 73.76 | 771.67 | 1568 | 10851 | 0.1445 | 0.2043 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.02 | 771.67 | 1466 | 11106 | 0.1320 | 0.1815 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.02 | 771.67 | 1616 | 11106 | 0.1455 | 0.2118 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.25 | 771.67 | 1456 | 11367 | 0.1281 | 0.1777 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.25 | 771.67 | 1568 | 11367 | 0.1379 | 0.2005 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 80.48 | 771.67 | 1460 | 11685 | 0.1250 | 0.1766 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 80.48 | 771.67 | 1582 | 11685 | 0.1354 | 0.2010 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.69 | 771.67 | 1461 | 11974 | 0.1220 | 0.1751 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.69 | 771.67 | 1574 | 11974 | 0.1315 | 0.1975 | MN20160304_L01 | H10 |